Emergent BioSolutions (Travel Vaccines) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Emergent BioSolutions (Travel Vaccines) General Information

Description

Developer of travel vaccine located in Maryland, United States. The company engages in produce vaccines for prevention of typhoid fever and vaxchora against cholera, thereby enabling to help protect against certain diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • MD
  • United States
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • MD
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emergent BioSolutions (Travel Vaccines) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Emergent BioSolutions (Travel Vaccines)‘s full profile, request access.

Request a free trial

Emergent BioSolutions (Travel Vaccines) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Emergent BioSolutions (Travel Vaccines)‘s full profile, request access.

Request a free trial

Emergent BioSolutions (Travel Vaccines) FAQs

  • Where is Emergent BioSolutions (Travel Vaccines) headquartered?

    Emergent BioSolutions (Travel Vaccines) is headquartered in MD.

  • What industry is Emergent BioSolutions (Travel Vaccines) in?

    Emergent BioSolutions (Travel Vaccines)’s primary industry is Drug Discovery.

  • Is Emergent BioSolutions (Travel Vaccines) a private or public company?

    Emergent BioSolutions (Travel Vaccines) is a Private company.

  • What is the current valuation of Emergent BioSolutions (Travel Vaccines)?

    The current valuation of Emergent BioSolutions (Travel Vaccines) is .

  • What is Emergent BioSolutions (Travel Vaccines)’s current revenue?

    The current revenue for Emergent BioSolutions (Travel Vaccines) is .

  • Who are Emergent BioSolutions (Travel Vaccines)’s investors?

    Emergent BioSolutions has invested in Emergent BioSolutions (Travel Vaccines).

  • When was Emergent BioSolutions (Travel Vaccines) acquired?

    Emergent BioSolutions (Travel Vaccines) was acquired on 15-Feb-2023.

  • Who acquired Emergent BioSolutions (Travel Vaccines)?

    Emergent BioSolutions (Travel Vaccines) was acquired by Bavarian Nordic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process